Studi, Tahun / Negara Pasien Umur BMI Nullipara (%) Multipara Smoking (%) Primigravida Multigravida (%)

(%) (%)

Covid/ Tidak Covid/ Tidak Covid/ Tidak Covid/ Tidak Covid Covid/ Tidak Covid/ Tidak Covid/ Tidak Covid/ Tidak
Covid Covid Covid Covid Covid Covid Covid
Ahlberg, 2020/ Sweden 115/604 32/32 26,5/26,5 39,7/40,9 1,9/1,2 2,6/3,6 NA/NA NA/NA

Papagiorghiou, 2020/ 123/2061 29,5/30,7 28,5/27,2 NA/NA 48,75/69,4 4,8/3,25 NA/NA NA/NA
Argentina, etc

Villar, 2020/ Argentina, 706/1424 NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA
etc

Steffen, 2021/ USA 61/939 28/30 NA/NA NA/NA NA/NA NA/NA NA/NA NA/NA

Perez, 2021/ Mexico 70/170 26/29 29/30 81/64 3/11 1/2 NA/NA NA/NA

Yang, 2020/ China 65/11013 NA/NA NA/NA NA/NA 37/42 75.2/52.9 42/42 58/58

Jering, 2021/ USA 6380/400066 28,3/29,1 NA/NA NA/NA NA/NA 1,4/4,7 NA/NA NA/NA

Prabhu, 2020/ USA 70/605 30,9/34 NA/NA NA/NA NA/NA 6,7/0,7 NA/NA NA/NA

Vousden, 2021/ UK 722/694 NA/NA NA/NA NA/NA 440/420 22/20 NA/NA NA/NA

Adhikari, 2020/ USA 252/3122 27/27,6 30,5/29,3 29/31 NA/NA NA/NA NA/NA NA/NA
Kalah Roudi, 2021/ Iran 55/94 NA/NA NA/NA 33,9/22,3 66,1/77,0 NA/NA NA/NA NA/NA
Wang, 2020/ USA 53/760 29,8/30,2 33,1/32,4 NA/NA NA/NA NA/NA NA/NA NA/NA
Crovetto, 2021/ Spanyol 317/1908 33,3/33,3 NA/NA 53/54,6 47/46,4 5,7/8,7 NA/NA NA/NA
Egerup, 2021/ Denmark 28/1285 31,5/31,5 23,9/23 61/54 NA/NA 3/0 NA/NA NA/NA
Rosenbloom, 2021/ USA 83/166 26/28 32/31 32/38 NA/NA NA/NA NA/NA NA/NA
Hcini, 2020/ France 137/370 25/25 26,1/26,6 21,9/25,4 NA/NA NA/NA NA/NA NA/NA
Trahan, 2021/ France 45/225 NA/NA NA/NA 33/38 67/63 NA/NA NA/NA NA/NA
Tores, 2021/ USA 103/106 28/29 32,6/33,1 31,1/27,2 NA/NA NA/NA 13,2/8,7 NA/NA
Melguizo, 2021/ Spanyol 1347/1607 33/33 NA/NA 38,7/40,4 NA/NA 10,2/12,8 NA/NA NA/NA
Urganci, 2021/ UK 3527/338553 NA/NA NA/NA NA/NA 57,1/58 NA/NA NA/NA NA/NA
Epelboin, 2021/ UK 874/243771 31,1/30,5 NA/NA NA/NA NA/NA 2,5/4,8 NA/NA NA/NA
Liu, 2021/ USA 56/279 30,3/29,8 NA/NA NA/NA NA/NA 3,6/9,3 NA/NA NA/NA
Table 1. Main characteristics of the included studies.
Table 1. Main characteristics of the included studies.
Table 2. New Castle Ottawa Scale of included studies
 Figure 1. Flower chart of the study selection process according to the Preffered Reporting Items for Systematic
rivews and Meta-Analyses (PRISMA statements)

Figure 1. All-cause mortality

Figure 2. Forest plots of early outcomes in intravascular ultra sound guided

versus angio- guided primary percutaneous coronary intervention
Figure 2. CV death

Figure 3. Early MACE

Figure 4. Long-term MACE

Figure 5. In-stent restenosis

Figure 3. Forest plots of long-term outcomes in intravascular ultra sound

Figure 6. Target vessel revascularization

guided versus angio- guided primary percutaneous coronary intervention

 Figure 4. Forest plots of secondary outcomes in intravascular ultra sound
guided versus angio- guided primary percutaneous coronary intervention

Figure 5. Funnel plots of all cause mortality and long-term MACE in

intravascular ultra sound guided versus angio- guided primary percutaneous
coronary intervention